Change in PDL Status for the Bronchodilators, Beta Agonist, Drug Class, Effective Jan. 3, 2025

Published on

VDP removed the non-preferred status from the generic levalbuterol inhalation solution products on the preferred drug list (PDL) effective Jan. 3, 2025, in response to the discontinuation of inhalation solution products with the preferred brand name Xopenex. Providers can prescribe the generic levalbuterol inhalation solution without requiring a PDL prior authorization, allowing clients to continue accessing necessary medication.

The following table lists the generic levalbuterol products with their National Drug Codes (NDCs):

NDCDrug Name
00093414556LEVALBUTEROL 0.31 MG/3 ML SOL
00115993078LEVALBUTEROL 0.31 MG/3 ML SOL
00378969052LEVALBUTEROL 0.31 MG/3 ML SOL
35573044325LEVALBUTEROL 0.31 MG/3 ML SOL
47335074349LEVALBUTEROL 0.31 MG/3 ML SOL
65862094324LEVALBUTEROL 0.31 MG/3 ML SOL
76204070001LEVALBUTEROL 0.31 MG/3 ML SOL
76204070025LEVALBUTEROL 0.31 MG/3 ML SOL
00115993178LEVALBUTEROL 0.63 MG/3 ML SOL
00378969152LEVALBUTEROL 0.63 MG/3 ML SOL
00093414656LEVALBUTEROL 0.63 MG/3 ML SOL
35573044425LEVALBUTEROL 0.63 MG/3 ML SOL
47335074649LEVALBUTEROL 0.63 MG/3 ML SOL
65862094424LEVALBUTEROL 0.63 MG/3 ML SOL
76204080001LEVALBUTEROL 0.63 MG/3 ML SOL
76204080025LEVALBUTEROL 0.63 MG/3 ML SOL
00093414856LEVALBUTEROL 1.25 MG/3 ML SOL
00115993278LEVALBUTEROL 1.25 MG/3 ML SOL
00378969252LEVALBUTEROL 1.25 MG/3 ML SOL
35573044525LEVALBUTEROL 1.25 MG/3 ML SOL
47335075349LEVALBUTEROL 1.25 MG/3 ML SOL
65862094524LEVALBUTEROL 1.25 MG/3 ML SOL
76204090001LEVALBUTEROL 1.25 MG/3 ML SOL
76204090025LEVALBUTEROL 1.25 MG/3 ML SOL
00378699393LEVALBUTEROL CONC 1.25 MG/0.5